Deprenyl in Tourette’s Syndrome and ADHD

Abstract

The efficacy of deprenyl, a monoamine oxidase inhibitor, was evaluated in the treatment of ADHD in 24 children and adolescents with comorbid Tourette’s syndrome (TS) enrolled at the University of Rochester and Baylor College of Medicine.

Keywords

• monoamine oxidase
• tourette’s syndrome
• adhd symptoms